Replies to post #1197 on Enanta Pharmaceuticals Inc (ENTA)

[DewDiligence]

Why this Merck doublet is expected to beat up on V-Pak?

The only way that could happen is if MRK were to start a price war. Fortunately, ABBV’s V-Pak contracts with ESRX and several other US payers are already established for 2016.